Nigeria Snakebite Research & Intervention Centre.
Technical co-Director, SRPNTS
Developing more effective, potent and safer monoclonal antibody therapy against snakebite envenoming will potentially have huge impact by curtailing death, disease and suffering in the developing world.
Bayero University, Kano
N-SRIC undertakes multi-disciplinary research and clinical activities leading to better diagnosis and therapies for snakebite, while working towards community-based model intervention systems with the primary goal of saving the lives and limbs of those afflicted with snakebite.
Abdul Habib serves as technical co-Director of the SRPNTS consortium with particular focus on clinical implementation. He is an infectious and tropical disease physician and epidemiologist. He was formerly Dean Faculty of Medicine and later Foundation Provost College of Health Sciences, Bayero University Kano, Nigeria (BUK). Abdul is a foundation member of the African Snakebite Research Group (ASRG) project that is supported by the NIHR (UK). He heads the Nigerian Snakebite Research Intervention Center (NSRIC), a member of the ASRG consortium and collaborator of the Center for Snakebite Research & Intervention (CSRI), Liverpool School for Tropical Medicine (LSTM), UK. Abdul is a member of several professional societies and the current president of the Nigerian Infectious Diseases Society, former Head of the Infectious Diseases Sub-Specialty at the West African College of Physicians and a Trustee of the Toxinology Society of Nigeria. He is currently serving as a member of the National Immunization Technical Advisory Group, National Drug Safety Advisory Committee and the chairman Noma (Cancrum Oris) Technical Advisory Group, Nigeria. He is an international advisor of the Royal College of Physicians, London (UK), a member of the Strategic Advisory Group of Experts (SAGE) on meningococcal meningitis vaccination at WHO, Geneva, Switzerland and a board member of the Global Snakebite Initiative (GSI).
MUBARAK MUHAMMAD MUSA